
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190

Zylox-Tonbridge Medical Technology Co Ltd
Treasury Stock
Zylox-Tonbridge Medical Technology Co Ltd
Treasury Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Treasury Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
|
Treasury Stock
-ÂĄ33.8m
|
CAGR 3-Years
-55%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
A
|
APT Medical Inc
SSE:688617
|
Treasury Stock
-ÂĄ60m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Treasury Stock
-ÂĄ113.4m
|
CAGR 3-Years
31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Treasury Stock
-ÂĄ324.8m
|
CAGR 3-Years
31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Treasury Stock
-ÂĄ608.5m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
![]() |
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Treasury Stock
-ÂĄ484.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Zylox-Tonbridge Medical Technology Co Ltd
Glance View
Zylox-Tonbridge Medical Technology Co., Ltd. operates as a medical devices company. The company is headquartered in Hangzhou, Zhejiang and currently employs 487 full-time employees. The company went IPO on 2021-07-05. The firm's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The firm's products are sold to domestic and foreign markets.

See Also
What is Zylox-Tonbridge Medical Technology Co Ltd's Treasury Stock?
Treasury Stock
-33.8m
CNY
Based on the financial report for Dec 31, 2024, Zylox-Tonbridge Medical Technology Co Ltd's Treasury Stock amounts to -33.8m CNY.
What is Zylox-Tonbridge Medical Technology Co Ltd's Treasury Stock growth rate?
Treasury Stock CAGR 3Y
-55%
Over the last year, the Treasury Stock growth was 0%. The average annual Treasury Stock growth rates for Zylox-Tonbridge Medical Technology Co Ltd have been -55% over the past three years .